BioCentury | Jan 13, 2016
Company News

Spark outlines 2018 goals

CEO Jeffrey Marrazzo said Spark Therapeutics Inc. (NASDAQ:ONCE) expects to have 10 clinical-stage gene therapy programs in the clinic by 2018, with data readouts from five programs expected by 1H17. The details came at a...
BioCentury | Dec 10, 2015
Product R&D

Spark in the brain

Spark Therapeutics Inc. is expanding beyond eye and blood diseases with its first foray into the brain for the rare neuronal disorder Batten disease, using a gene therapy delivered to the ependymal cells in the...
Items per page:
1 - 2 of 2